Parity and endometrial cancer risk: A meta-analysis of epidemiological studies

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Qi Jun ^a   Li, Yuan Yuan ^b   Tu, Chao ^c   Zhu, Jingjing ^d,e   Qian, Ke Qing ^c   Feng, Tong Bao ^c   Li, Changwei ^f   Wu, Lang ^e,g   Ma, Xiao Xin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF MINNESOTA   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f TULANE UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN; META ANALYSIS; ODDS RATIO; PARITY; PREGNANCY; RISK;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; ODDS RATIO; PARITY; PREGNANCY; RISK;

EID: 84942049638     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14243     Document Type: Article

References (52)

1. Hill, H. A. and Austin, H. Nutrition and endometrial cancer. Cancer Causes Control 7, 19-32 (1996).
2. Key, T. J. and Pike, M. C. The dose-effect relationship between unopposed oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57, 205-212 (1988).
3. Dossus, L. et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127, 442-451, doi: 10.1002/ijc.25050 (2010).
4. Kvale, G., Heuch, I. and Ursin, G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res 48, 6217-6221 (1988).
5. Fujita, M. et al. Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: a case-control study. Tohoku J Exp Med 216, 297-307 (2008).
6. Parslov, M. et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol 182, 23-29 (2000).
7. Salazar-Martinez, E. et al. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res 59, 3658-3662 (1999).
8. Kalandidi, A. et al. A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology 53, 354-359 (1996).
9. Shu, X. O. et al. A population-based case-control study of dietary factors and endometrial cancer in Shanghai, Peoples Republic of China. Am J Epidemiol 137, 155-165 (1993).
10. Brons, N., Baandrup, L., Dehlendorff, C. and Kjaer, S. K. Use of nonsteroidal anti-inflammatory drugs and risk of endometrial cancer: a nationwide case-control study. Cancer Causes and Control 26, 973-981, doi: 10.1007/s10552-015-0578-4 (2015).
11. Hachisuga, T. et al. Risk factors for endometrial cancer in Japanese women. International Journal of Gynecological Cancer 8(4), 292-297, doi: http://dx.doi.org/10.1046/j.1525-1438.1998.09786.x (1998).
12. Wang, P. [A case-control study on endometrial carcinoma]. Zhonghua Liu Xing Bing Xue Za Zhi 11, 356-359 (1990).
13. Setiawan, V. W. et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31, 2607-2618, doi: 10.1200/JCO.2012.48.2596 (2013).
14. Terry, P. et al. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 82, 38-42 (1999).
15. Parazzini, F. et al. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 76, 784-786 (1998).
16. Koumantaki, Y. et al. A case-control study of cancer of endometrium in Athens. Int J Cancer 43, 795-799 (1989).
17. La Vecchia, C., Franceschi, S., Decarli, A., Gallus, G. and Tognoni, G. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 73, 667-671 (1984).
18. Castellsague, X., Thompson, W. D. and Dubrow, R. Intra-uterine contraception and the risk of endometrial cancer. Int J Cancer 54, 911-916 (1993).
19. Dahlgren, E. et al. Endometrial carcinoma; ovarian dysfunction-a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 41, 143-150 (1991).
20. Elwood, J. M., Cole, P., Rothman, K. J. and Kaplan, S. D. Epidemiology of endometrial cancer. J Natl Cancer Inst 59, 1055-1060 (1977).
21. Hosono, S. et al. Weight gain during adulthood and body weight at age 20 are associated with the risk of endometrial cancer in Japanese women. J Epidemiol 21, 466-473 (2011).
22. Jaakkola, S., Lyytinen, H. K., Dyba, T., Ylikorkala, O. and Pukkala, E. Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study. Int J Cancer 128, 1644-1651, doi: 10.1002/ijc.25762 (2011).
23. Lesko, S. M. et al. Endometrial cancer and age at last delivery: evidence for an association. Am J Epidemiol 133, 554-559 (1991).
24. Salmi, T. Risk factors in endometrial carcinoma with special reference to the use of estrogens. Acta Obstetricia et Gynecologica Scandinavica 58, 1-119 (1979).
25. Hao, J. Z., Zhang, S. W., Wang, T. and Deng, X. H. Epidemiological study of endometrial cancer in Beijing. [Chinese]. Chinese Journal of Cancer Prevention and Treatment 16(11), 805-809 (2009).
26. Asakura, S., Mori, M., Suzuki, T. and Saito, T. A case-control study of endometrial cancer especially with reference to lifestyle and other factors of Japanese women. Sapporo Medical journal 78(1-6), 19-30 (2009).
27. Wernli, K. J. et al. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control 17, 949-955, doi: 10.1007/s10552-006-0034-6 (2006).
28. Albrektsen, G., Heuch, I., Tretli, S. and Kvale, G. Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 Norwegian women. Int J Cancer 61, 485-490 (1995).
29. Bevier, M., Sundquist, J. and Hemminki, K. Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? Eur J Cancer 47, 586-591, doi: 10.1016/j.ejca.2010.10.004 (2011).
30. Henderson, B. E. and Feigelson, H. S. Hormonal carcinogenesis. Carcinogenesis 21, 427-433 (2000).
31. Akhmedkhanov, A., Zeleniuch-Jacquotte, A. and Toniolo, P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci 943, 296-315 (2001).
32. Kaaks, R., Lukanova, A. and Kurzer, M. S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 11, 1531-1543 (2002).
33. Brinton, L. A. et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167, 1317-1325 (1992).
34. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A. and Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res 50, 7415-7421 (1990).
35. Lambe, M., Wuu, J., Weiderpass, E. and Hsieh, C. C. Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes Control 10, 43-49 (1999).
36. Gierisch, J. M. et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22, 1931-1943, doi: 10.1158/1055-9965.EPI-13-0298 (2013).
37. Ioannidis, J. P., Patsopoulos, N. A. and Evangelou, E. Uncertainty in heterogeneity estimates in meta-analyses. Bmj 335, 914-916, doi: 10.1136/bmj.39343.408449.80 (2007).
38. Wu, Q. J. et al. Consumption of fruit and vegetables reduces risk of pancreatic cancer: evidence from epidemiological studies. Eur J Cancer Prev, doi: 10.1097/CEJ.0000000000000171 (2015).
39. Wu, L., Zhu, J., Prokop, L. J. and Hassan Murad, M. Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies. Sci Rep 5, 10147, doi: 10.1038/srep10147 (2015).
40. Wu, L. et al. Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis. Nutr Rev 73, 409-425, doi: 10.1093/nutrit/nuv006 (2015).
41. Wang, Y. Z., Wu, Q. J., Zhu, J. and Wu, L. Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies. Cancer Causes Control, doi: 10.1007/s10552-015-0625-1 (2015).
42. Wu, L. and Zhu, J. Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies. Hum Reprod, doi: 10.1093/humrep/dev160 (2015).
43. Wells, G. A., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. (Date of access: 07/04/2015)
44. Higgins, J. P., Thompson, S. G., Deeks, J. J. and Altman, D. G. Measuring inconsistency in meta-analyses. Bmj 327, 557-560, doi: 10.1136/bmj.327.7414.557 (2003).
45. Higgins, J. P. and Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558, doi: 10.1002/sim.1186 (2002).
46. DerSimonian, R. and Laird, N. Meta-analysis in clinical trials. Controlled clinical trials 7, 177-188 (1986).
47. Greenland, S. and Longnecker, M. P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301-1309 (1992).
48. Guan, H. B., Wu, L., Wu, Q. J., Zhu, J. and Gong, T. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies. PloS one 9, e92738, doi: 10.1371/journal.pone.0092738 (2014).
49. Luan, N. N. et al. Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-analysis of epidemiological studies. Cancer Causes Control, doi: 10.1007/s10552-014-0483-2 (2014).
50. Orsini, N., Li, R., Wolk, A., Khudyakov, P. and Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66-73, doi: 10.1093/aje/kwr265 (2012).
51. Liu, Q., Cook, N. R., Bergstrom, A. and Hsieh, C. C. A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose-response data. Computational Statistics and Data Analysis 53, 4157-4167 (2009).
52. Begg, C. B. and Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101 (1994).